|
Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide |
Shaughnessy P, Islas-Ohlmayer M, Murphy J, Hougham M, MacPherson J, Winkler K, Silva M, Steinberg M, Matous J, Selvey S, Maris M, McSweeney PA |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Shaughnessy P, Islas-Ohlmayer M, Murphy J, Hougham M, MacPherson J, Winkler K, Silva M, Steinberg M, Matous J, Selvey S, Maris M, McSweeney PA. Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide. Biology of Blood and Marrow Transplantation 2011; 17(5): 729-736 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Antigens, CD34 /analysis; Antineoplastic Agents /administration & Blood Component Removal /economics /utilization; Case-Control Studies; Cost-Benefit Analysis; Cyclophosphamide /administration & Female; Granulocyte Colony-Stimulating Factor /administration & Health Care Costs; Hematopoietic Stem Cell Mobilization /economics /methods; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds /administration & Humans; Male; Middle Aged; Retrospective Studies; Transplantation, Autologous; United States; dosage; dosage; dosage; dosage AccessionNumber 22011000769 Date bibliographic record published 24/08/2011 |
|
|
|